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Background/aim: The objective of this study was to investigate and analyze the behavioral and neurochemical effects of monosodium
glutamate (MSG) injections at various and subsequent dosages on male Wistar rats during the neonatal period.
Materials and methods: In order to determine the behavioral and neurochemical effects of MSG, the experiment was implemented on
neonatal male Wistar rats and the test was repeated for various MSG dosages. After completing the experiment, additionally, levels of
dopamine, GABA, catecholamine (dopamine, noradrenaline, and adrenaline) and glutamate in the brain cells of the decapitated rats
were also measured using the ELISA method.
Results: Considering the results of the behavioral test, when we compared the test values of the control group with the values of the
MSG-injected groups we noted that there were significant differences in the statistical figures obtained. Additionally, we found that the
statistical figures of some neurochemical parameters were also significantly different when we compared the values of the MSG group
with the control values.
Conclusion: MSG injection has a clear effect on the neurochemical parameters, learning memory, and locomotor activities of rats.
Key words: Monosodium glutamate, behavioral analysis, neurochemical analysis

1. Introduction
Glutamate is one of the excitatory amino acids that already
exist in the brain’s own structure. It serves as a medium for
the transmission of the fast synaptic in the whole central
nervous system (CNS) (1). Monosodium glutamate (MSG)
increases the savor of foods and stimulates the nerves, and
so it causes more and more frequent food cravings. The
main reason for the use of such an additive is that MSG has
a better and more rapid dissolution performance compared
to glutamic acid (2,3). Regardless of the dietary sources,
all of the glutamate molecules entering the circulation
through the gastrointestinal tract are structurally identical
(4). A large portion of the glutamate accessing the human
body is absorbed through the intestinal lumen (5). It is in
the CNS that the presence of a glutamate signaling system
was first revealed (6). It is detected that the system has
a function in nonneuronal tissues affected by the CNS,
such as bone, liver, pancreas, and skin (6,7). Glutamate
is considered to be the major excitatory neurotransmitter
in the mammalian CNS, where it has a role of mediator
during the creation of sensory and cognitive formations
* Correspondence: aysencetin@yahoo.com
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such as the usage of sensory information, maintenance of
the motor coordination, and retrieval of the memory (8).
In the case of a glutamate overdose in mature animals, even
if blood–brain barrier penetration prevention is achieved,
neuronal cell deaths are induced (9). When MSG is applied
to animals during the neonatal period, pyramidal cells in
the hippocampal CA1 suffer more histological damage
compared to the other regions of the brain comprising the
cerebral cortex (9).
The neurotoxin effect of MSG appears as brain cell
damage, retinal degeneration, and endocrinal diseases
and in some pathological cases such as addiction, stroke,
epilepsy, brain trauma, neuropathic pain, schizophrenia,
anxiety, depression, Parkinson disease, Alzheimer disease,
Huntington disease, and amyotrophic lateral sclerosis
(10). Experimental studies related to that subject were
first initiated after the determination of neuronal death
(necrosis) at the brain’s arcuate nucleus hypothalamus,
due to orally applied MSG in newborn mice by Olney in
1970 and by Hu et al. in 1998 (11,12). In 1957, in their
pioneering studies, Lucas and Newhouse pointed out
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the loss of neuronal cells in the retina and Olney in the
hypothalamic arcuate nucleus. They discovered that a
high amount of MSG, when implemented in a repetitive
and systemic manner, results in neuronal death through
a mechanism called excitotoxicity, which is depending
on the intracellular Ca++ increase triggered by the Glu
receptors’ (GluR) overactivation (11,13).
Gill (14) and Hughes et al. (15) have concluded that
MSG played a key role resulting in the death of neuronal
cells. Similar outcomes were obtained by Reistad et al.
(16), who have declared that glutamate is the root cause of
the death of cerebellar granule cells in the primary cellular
culture environment. Additionally, Rogers et al. (5) have
proven that MSG was the main cause of apoptosis, necrosis,
and learning and memory impairment and they have
determined that MSG caused selective neurodegeneration.
The objective of the present study was to investigate the
presence of a correlation between injections of MSG and
the behaviors and neurochemical parameters of Wistar rats
subjected to those injections during the neonatal period.
2. Materials and methods
2.1. Examined animal groups
Six neonatal male Wistar rats were selected as the control
group. After completing their behavioral tests, the rats
were subjected to injections in the form of intraperitoneal,
normal saline, scheduled and implemented as 1 injection
per day and 1 day free after each injection, 8 times in
total. Eighteen neonatal male Wistar rats were subjected
to injections of MSG (C5H8NNaO4.H2O, ≥98.0% (NT),
MV: 187.13 g/mol, Sigma, USA) after the completion
of their behavioral tests. Injections were scheduled and
implemented as 1 injection per day and 1 day free after
each, 8 times in total. Injected MSG dosages were as
follows:
Group 1: 50 mg/kg per day, 6 rats
Group 2: 100 mg/kg per day, 6 rats
Group 3: 200 mg/kg per day, 6 rats
2.2. Behavioral analysis
Eight-arm radial maze test specifications: In order to test
the learning and memory functions of the rats we selected
an 8-arm radial maze test setup. Each of the arms has a
length of 50 cm and width of 10 cm. Each arm is covered
with a housing made of glass. In the middle of the maze
setup a central zone is built in order to allow access to other
arms of the maze. Animals are unleashed in that central
zone and then they are subject to the test. The 8-arm radial
maze test setup stands on 3 pillars and its height is 80 cm
from the floor. The walls of the room where the maze setup
is located are completely painted white. Colored boards
are placed around the maze in order to help the animals
to find their way in the maze. The test is conducted in a
fully silent ambient. The maze is illuminated from top to

downward using 3 electrical light sources. Food rewards
are placed at the distal end of each arm. During the test,
rewards are not refreshed after they are consumed by the
animals and at the end of the test each arm is cleaned with
alcohol. As we know that learning in the maze is related to
starving, food restriction is applied prior to the start of the
test until the animals reach 85% of their normal weight, in
order to increase their motivation to seek food. The test is
scheduled for each animal as 3 trials per day over 14 days.
Training for the 8-arm radial maze test: Prior to
the start of the test, the animals are trained in the maze
without any MSG injection. The training program includes
a warm-up period of 3 days and a training period of 14
days subsequently. The duration of each training session is
10 min. A session is terminated if an animal completes its
visit to all of the 8 arms of the maze before the end of the
projected 10 min duration. Following the training sessions,
starting on days 1, 7, 14, 21, and 28 of MSG injections, the
8-arm radial maze test is performed with the animals.
Application of the 8-arm radial maze test: After the
3-day warm-up period and training period of 14 days, MSG
injections of each group are completed. MSG injections
consist of 8 dosages in total, each implemented as one
dosage in the following order subsequently (day 0, day 1,
day 7, day 14, day 21, and day 28). The weight of each animal
is measured before injecting the related MSG dosage. After
that, similar to the training period, the 8-arm radial maze
test is implemented 3 days a day over the next 14 days.
Considering the results of the 8-arm radial maze test,
calculations are made accordingly in 2 different manners:
Number of correct accesses: Refers to the number of
times access to the correct arm was achieved by the animal.
Response latencies: Total time spent in the maze/
Number of arms accessed.
- Definition of the total time spent in the maze:
a) Total time spent by the animal if it has completed all
of the 8 accesses in less than 10 min.
b) If the animal did not access all of the 8 arms within 10
min, then the test is terminated. In this case total time spent
is taken as 10 min (600 s).
Open field test procedure: The open field test setup
consists of a square field with dimensions of 45 × 45 cm
and it is illuminated by 3 fluorescent bulbs. The top of the
field is open to the ambient and the square field is bordered
by white stripes each of 1 cm width on a black background.
Each of the experimental animals are brought to the center
of the open field setup and released to move freely. Duration
of the test is determined as 3 min, during which the rats
are observed closely and their behaviors are recorded as line
crossing, rearing, and grooming.
2.3. Neurochemical analysis
Following the MSG injections, brain tissues of the
decapitated rats were stored in a freezer at –20 °C. The
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levels of dopamine, glutamate, GABA, and catecholamine
in those brain tissues (frontal lobe for dopamine, GABA,
and catecholamine, and cerebellum for glutamate) were
measured by the means of a test kit. The test kit was based
on an enzyme linked immunosorbent assay (ELISA)
(Cusabio, China).
2.4. Statistical analysis
The experimental data compiled during the tests were
analyzed by SPSS 21.0. Continuous variables were
expressed as mean ± standard deviation and median
(minimum–maximum values). Kruskal–Wallis variance
analysis was used for intergroup comparisons. The posthoc Mann–Whitney U test with Bonferroni correction
was used when the Kruskal–Wallis variance analysis
determined a significant difference. The Wilcoxon signed
rank test was used for pre–post comparisons.
3. Results
3.1. Behavioral analysis
Behaviors parameters obtained from the 8-arm radial
maze test are given in Table 1.
Following the completion of the training period
in the 8-arm radial maze test setup, the control group

and the groups subjected to MSG injections at various
dosages were monitored on a weekly basis and the results
obtained as the number of correct behaviors and response
latencies were analyzed statistically by Kruskal–Wallis
and Friedman testing methods. Number of mistaken
behaviors refers to the frequency at which the rat enters
the same section twice. Visits to the same section twice or
more are accepted as mistaken behavior. Values taken into
consideration are the ones measured prior to the injection
and on the following 1, 7, 14, 21, and 28 days after the
injection.
In Table 1, MSG 50 refers to the group given 50 mg/
kg per day monosodium glutamate, MSG 100 refers to the
group given 100 mg/kg per day monosodium glutamate,
and MSG 200 refers to the group given 200 mg/kg per day
monosodium glutamate. Compared to the control group,
in the group subjected to the injection of MSG 200 mg/
kg per day, a statistically considerable decrease in the
number of correct behaviors was observed on day 7 of
the experiment (between MSG 50 dosage and MSG 200
dosage, control group and MSG 200 dosage) (P < 0.002)
(Figure 1).
On day 14 of the experiment, when the group of MSG
100 is compared with the control group and with the group

Table 1. Effect of MSG on the numbers of correct behaviors and response latency values in the 8-arm radial maze.
Number of correct behaviors

Control

Preinjection

Day 1

Day 7

Day 14

Day 21

Day 28

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

P

7 (6–7)

7 (6–8)

8 (6–8)

8 (6–8)

7 (6–8)

8 (5–8)

0.293

MSG 50

6.5 (6–7)

6.5 (4–8)

8 (7–8)

7 (6–8)

7 (5–8)

7 (4–8)

0.215

MSG 100

6 (6–7)

6 (1–8)

6.5 (5–8)

7 (6–8)

6 (5–7)

6.5 (4–8)

0.594
0.087

MSG 200

7 (6–7)

5 (1–6)

5 (5–6)

6 (2–7)

6.5 (5–8)

4.5 (4–8)

P

0.622

0.075

0.002*

0.1

0.362

0.074

Preinjection

Day 1

Day 7

Day 14

Day 21

Day 28

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

Median
(min–max)

P

Control

19 (12–30)

18 (13–29)

14 (10–51)

15 (11–28)

17.5 (14–41)

11 (6–18)

0.126

MSG50

11.5 (9–20)

18.5 (16–150)

12.5 (9–35)

17 (11–30)

12 (9–18)

14 (8–20)

0.051

MSG100

13.5 (9–21)

30.5 (12– 300)

18.5 (8–46)

45 (42–55)

29 (11–67)

15 (11–20)

0.023*+

MSG200

19 (14–39)

57 (16–200)

18 (16–49)

22 (13–31)

21.5 (12–59)

16 (11–44)

0.089

P

0.118

0.327

0.721

0.004**

0.102

0.259

Response latencies

Number of correct behaviors; control and MSG 50 are significantly different from MSG 200 (P < 0.002*). Response latency; control and
MSG 50 are significantly different from MSG 100 (P < 0.004**). The values preinjection and on day 7 are significantly different from the
values of day 14. In addition, the values on day 14 are significantly different from the values on day 28 at MSG 100 dosage (P < 0.023*+).
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Figure 1. Numbers of correct accesses preinjection are
significantly different from the numbers for day 7 for the MSG
50 mg/kg and MSG 200 mg/kg groups (P < 0.002*). Additionally,
the control group’s number is significantly different from the
MSG 200 group’s value (P < 0.002+). Statistically significant value
is P < 0.05.

of MSG 50, a statistically reasonable decrease is observed
in the response latency results (P < 0.004) (Figure 2a).
Similarly, again based on the response latency results,
statistically reasonable differences are detected in the MSG
100 group when the preinjection values are compared with
the values of day 15, the values of day 7 with the values of
day 14, and the values of day 14 with the values of day 28
(P < 0.023) (Figure 2b).
Response latency results display statistically significant
differences according to various MSG dosages applied in
Table 1, when compared with the values of preinjection
and of day 14, with the values of day 7 and day 14, and
with the values of day 14 and day 28 (P < 0.023). There is
also a statistically significant difference between the results
of the response latency of the control group and the MSG
100 group, and between the MSG 50 group and the MSG
100 group as well on day 14 (P < 0.004).
Line crossing, rearing, and grooming values
are given for the applied MSG dosages before and after the
injections in Table 2. A statistically significant difference
is determined between the line crossing value when the
control group and MSG dosages (MSG 50 - MSG 200)
pre- and postinjections are compared (P < 0.05). In the
postinjection period, only the grooming values of the
control group are considered to be significant (P < 0.05).
Rearing values are determined to be statistically significant
for both the preinjection and postinjection periods at all
given MGS dosages applied (P < 0.05).

3.2. Neurochemical analysis
Dopamine, GABA, glutamate, and catecholamine levels
in decapitated rats’ brain tissues were measured using
ELISA. GABA, dopamine, and other catecholamine levels
(noradrenaline and adrenaline) were inspected in the
brains’ frontal lobe and the level of glutamate was inspected
in the cerebellum. For both regions, neurochemical values
with respect to relevant MSG dosages are given in ELISA
results (Table 3). Significant differences in catecholamine
levels (noradrenaline and adrenaline) measured were
detected in the following couples of dosage groups when
compared with each other: control group and MSG 50
dosage group, control group and MSG 100 dosage group,
MSG 100 dosage group and MSG 200 dosage group, and
MSG 50 dosage group and MSG 200 dosage group (P <
0.017) (Figure 3a). In addition to catecholamine levels,
significant differences were also detected in the glutamate
levels of the MSG 50 dosage group and the MSG 100
dosage group when compared with the control group’s
glutamate level (P < 0.029) (Figure 3b).
4. Discussion
In recent years, there have been continuous and ongoing
discussions about the neurobehavioral effects of MSG.
Meanwhile experiments to reveal its possible effects
on animals are still being conducted. Artificial flavor
enhancers such as MSG may cause animals to display
behaviors similar to anxiety, epilepsy, and depression
(17–21). Behaviors similar to anxiety can be identified
by the means of experimental open field test, light/dark
transition test, elevated plus maze test, tail suspension test,
forced swim test, and social interaction task (22). Through
the open field test, line crossing, rearing, grooming, and
defecation number parameters of rats can be assessed (23).
In our study, the open field test was conducted with rats
both before and after the MSG injections. This allowed us
to evaluate and compare the functions of the locomotor
activities of rats in the MSG-injected group and the control
group.
Dubovickyet et al. (24) revealed that MSG injections
during the neonatal period of rats increased locomotor
behavior on postnatal days 21 and 65. Ishikawa et al. (9)
also stated that MSG injections performed during the
neonatal period caused some specific degeneration in
the hippocampal CA1 pyramidal cells, which is linked to
learning disability. Kiss et al. (25) and López Pérez et al.
(26) reported that, on postnatal days 1, 3, 5, 7, and 9, rats
who were subjected to MSG injections firstly displayed
increased locomotor activities and afterwards hypoactivity,
and finally behavioral disorders.
All the above statements taken from previous research
support the argument that the degeneration in the
hippocampal area of the brain caused by the MSG also
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Figure 2. a) Compared to the preinjection phase, response latency values of the MSG 50 mg/kg and MSG 100 mg/kg groups are
significantly different from each other on day 14 of the test (P < 0.004*). Additionally the control group’s value is significantly
different from the value of the MSG 100 mg/kg group (P < 0.004+). b) Response latency value for MSG 100 mg/kg; values in the
preinjection phase and on day 7 are significantly different from the value on day 14 (P < 0.023*,+), day 14’s value is also significantly
different from the value of day 28 (P < 0.023×).

Table 2. Open field test results for various MSG dosages in the preinjection and postinjection periods.
Preinjection

Line crossing

Grooming

Rearing

Postinjection

Means ± SEM

Median
(min–max)

Means ± SEM

Median
(min–max)

P

Control

32.8 ± 17.8

30.5 (10–56)

30.8 ± 17.3

28.5 (9–53)

0.024*

MSG 50

51.5 ± 7.8

50.5 (43–62)

23.5 ± 10.0

20.0 (13–40)

0.027*

MSG 100

53.8 ± 23.3

49.0 (34–99)

18.1 ± 9.7

19.5 (4–31)

0.028*

MSG 200

60.0 ± 12.3

59.0 (42–78)

23.8 ± 7.2

26.5 (11–31)

0.028*

Control

20.6 ± 7.6

19.5 (13–34)

14.0 ± 4.3

13.0 (9–20)

0.026*

MSG 50

19.1 ± 23.0

9.5 (8–66)

52.0 ± 29.5

57.0 (4–84)

0.116

MSG 100

26.0 ± 29.6

14.0 (0–80)

49.6 ± 24.0

47.5 (19–85)

0.116

MSG 200

42.1 ± 23.3

38.5 (13–81)

39.5 ± 22.7

34.5 (15–80)

0.917

Control

6.0 ± 1.1

6.0 (5–7)

4.7 ± 0.9

4.5 (4–6)

0.059

MSG 50

11.0 ± 3.5

10.0 (8–17)

4.0 ± 2.6

3.0 (2–9)

0.026*

MSG 100

8.8 ± 3.0

8.5 (4–13)

2.6 ± 1.2

2.5 (1–4)

0.027*

MSG 200

13.1 ± 5.9

14.0 (6–19)

3.1 ± 1.4

3.5 (1–5)

0.028*

Significantly different from the preinjection value (P < 0.05*).
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Table 3. GABA, dopamine, catecholamine, and glutamate levels in rats’ brain tissues.

GABA (pg/mL)

Dopamine (ng/mL)

Catecholamine (pg/mL)

Glutamate (nmol/µL)

Mean ± SEM

Median (min–max)

Control

2.46 ± 3.44

1.18 (0.61–9.46)

MSG 50

1.11 ± 0.67

1.17 (0.35–2.2)

MSG 100

0.92 ± 0.37

0.94 (0.53–1.36)

MSG 200

0.74 ± 0.24

0.73 (0.47–1.02)

Control

0.8 ± 0.36

0.63 (0.54–1.46)

MSG 50

0.85 ± 0.15

0.91 (0.57–0.97)

MSG 100

0.96 ± 0.3

0.97 (0.53–1.43)

MSG 200

2.19 ± 2.72

0.7 (0.5–7.19)

Control

32.83 ± 5.31

30.62 (27.31–41.74)

MSG 50

41.45 ± 4.84

40.9 (34.98–47.46)

MSG 100

41.19 ± 7.7

41.14 (27.97–50)

MSG 200

30.63 ± 4.65

32.14 (21.25–33.54)

Control

0.22 ± 0

0.22 (0.22–0.23)

MSG 50

0.26 ± 0.04

0.23 (0.22–0.31)

MSG 100

0.24 ± 0.01

0.24 (0.22–0.24)

MSG 200

0.23 ± 0.01

1.23 0.22–0.24)

P

0.26

0.693

0.017*

0.029**

Catecholamine levels of the MSG groups (50, 100, 200 mg/kg) are significantly different from the values of the
control group (P < 0.017)*. Glutamate levels of the MSG (50, 100, 200 mg/kg) groups are significantly different
from the values of the control group (P < 0.029**).

Figure 3. a) Catecholamine level; the values of the MSG 50 mg/kg and MSG 100 mg/kg groups are significantly different from the
control group’s value. Additionally, the values of the MSG 50 mg/kg and MSG 100 mg/kg groups are significantly different from
the value of MSG 200 (P < 0.017*,+,-,×). b) Glutamate level; MSG 50 and MSG 100 were significantly different from the control (P
< 0.029*,+).

has an effect on behavioral parameters. According to the
statistical results of our study, line-crossing values of the
rats that were subjected to MSG injections were lower

than the control group’s values. Similar results showing
decreases in motor activities were reported previously (27–
29). Additionally, after the MSG injections, an increase in
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grooming values and a decrease in rearing values were also
observed. Studies by Oliveira de Almeida et al. (30) were
the first to report that the animal became more hypoactive
and also rooming number increased after MSG injections.
They evaluated the expression of dopamine D2 receptor
via western blot analysis and implemented an open field
test on day 57 of their experiment on rats. Briefly, after 57
days, they observed that following a significant decrease in
locomotor activities the rats became less active compared
to their initially measured behaviors. However, after day
71 those values returned to their initial numbers. Similarly,
in an experimental model based on nicotine, which is
known as an oxidant agent, the open field test resulted in
reduced motor activity and in an increased level of anxiety
in animals (31). On the other hand, in an experimental
model built to observe epilepsy at rats, a significant
increase in locomotor activities was determined via the
measurements made in the open field test (20).
In our study, we tested the learning and memory
functions of rats in an 8-arm radial maze, both before
and after the MSG injections. In order to determine the
appropriate MSG dosage to be injected, the weight of each
rat was measured prior to injection.
MSG dosages consisted of 8 subsequent dosages in
order to observe its acute and chronic effects on rats. Based
on the results of the 8-arm radial maze test, we observed
that the number of times the rats chose the correct arm
decreased for the MSG-injected rats compared to the
control group on day 7. However, response latency
increased on day 14. The fact that the increase happens
mostly on day 14 of the MSG injections raises the idea
that some defects occur in the spatial memory of animals
(32). In the radial maze test it was proved that there is a
correlation between spatial learning and the density of
the brain’s receptors. There are two arguments to prove
this correlation: first is the increase in the increasing
reward system due to the facilitating effect GABAA in the
emission of noradrenalin in the hippocampus; in this case
food reward tasks might be the focus. Second is the high
positive correlation between the GABAA receptors, AMPA
receptors, and universal receptors (33). GABA is emitted
in the brain due to the dopamine level (34). Oliveira de
Almeida et al. (30) examined the effect of dopaminergic
increase on the locomotor activity of rats and its relation
with the expression of dopamine D2 receptor. They argued
that the increased expression of dopamine receptor D1
compared to the receptor D2 reduced the locomotor
activity and thus caused a decrease in mobilization. Similar
findings have also been recorded in other studies (27,35).
In our study, we observed that as the MSG dosages
were increased throughout the experiment the level of
dopamine increased but the GABA level decreased. Due
to that decrease, a feedback inhibition occurred in the
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cortex and hippocampus, in order to maintain a balanced
glutamate/GABA ratio (even the level of dopamine is
increased) (36). Those abnormalities in neurochemical
levels were also reported previously (37–39). In our study,
the increase in glutamate level and decrease in GABA level
revealed that the same mechanism exists in the animals
subjected to higher MSG dosage injections. Additionally,
the presence of a positive correlation between GABA
receptor density and spatial learning, according to Schmid
et al. (33), is potentially a good explanation for the
decrease in the GABA level and the decrease (or change)
in the learning parameters observed in the radial maze test
results.
On the other hand, it is thought that there is a balance
between the excitatory neurotransmitter glutamate levels
and the inhibitory neurotransmitter GABA levels and that
this balance is of core importance for the hippocampal
circuits since any diversion in favor of one of those systems
may cause an imbalance in dysfunctions (33).
Excessive glutamate activation allows the neurological
circuit to widen its range of effect in infant mice (40) and
induces long-term depression in rats (41). Bojanic et al.
reported that MSG can act as an ‘excitotoxin’; this means
that it could overstimulate the neural cells up to the point
of damage or even to death (42).
In our study we observed that compared to the control
group the glutamate level increased as much as the level
of MSG dosage was increased relatively. The reason is
that normally the concentration of glutamate released
into the synaptic range could reach very high levels but
those levels could only be maintained just for a couple of
milliseconds. If the duration is extended, overstimulation
of neuronal glutamate receptors occurs and neurons face a
lethal excitation. During the ischemia, intensive glutamate
accumulation stimulates the glutamate receptors,
triggering a series of reactions leading to neuronal death.
It is assumed that, as a result of ischemia, lower oxygen
concentration prevents the recovery of energy dependent
glutamate and it causes an increased level of extracellular
glutamate (43).
Dopamine and other monoamines such as
catecholamine are neuroactive substances that exist
abundantly in the CNS (37). Catecholamines are of core
importance in building learning abilities and also in the
formation of the memory (44). We also observed that the
catecholamine level decreased as the dosage of MSG was
increased. We think that the decrease in the catecholamine
level related to increased MSG dosage is a neurochemical
reason for the learning disorder and for the loss of some
functions related to memory. From a biochemical point of
view (increase in glutamate, decrease in GABA, increase
in dopamine, and decrease in the other catecholamines)
the results obtained are consistent with the number of
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times the correct arm in the radial maze was accessed and
with the response latency values. As a result, we concluded
that while the MSG dosage is increased, the balance
between the ratio of glutamate/GABA and dopamine/
catecholamine may have caused the animal to select the
right arm in the maze and increase the response latency
value. We think that, after the MSG injections, such
changes like necrosis and immunopathological expression
changes happening in the brain’s hippocampus CA1
area and the brain’s arcuate nucleus cortex may result
in some behavioral changes in the animals, during their
acute and chronic periods. Ultimately, cerebral ischemia
and reperfusion form mechanisms that affect the spatial
memory and motor sensors negatively (45).
In a study in which the effects of the hippocampus,
amygdale, and the dorsal striatum on the learning and the
memory of animals were investigated, behavioral effects
of lesions created in the three areas of the brain were
investigated via an 8-arm radial maze (37). According to
the results of that study, the hippocampus is responsible for
the relations between the stimulants and the events in the
nerve system. The results indicate that the hippocampus
provides information about the nerve system and also
about the behaviors based on important biological events.
However, in the same study, it was mentioned that the
dorsal striatum contributes to the union of stimulant–
reaction improved by the nerve system (37).

Furthermore, the hippocampus also contributes to the
operation of a vast variety of neuronal functions including
the support and protection of motor neurons in astrocytes.
However, in the case where astrocytes are overactivated,
their forms and motor neuron functions are also altered.
Activation of astrocytes in the brain is a characteristic
general pathological situation. In this case, an irregular
communication may appear between the motor neurons
and astrocytes and ultimately the death of motor neurons
is accelerated (46). In a study in which the expressions of
the neuronal marker MAP-2 and astroglial marker GFAP
were examined, the expression of MAP-2 decreased but
the expression of GFAP increased due to an extracellular
increase in glutamate (47). When the astrocytes were
activated, the expression of GFAP sharply increased
(48,49).
In conclusion, MSG negatively affects the learning/
memory functions of animals in addition to its effects on
their behavioral parameters such as anxiety, depression,
and similar behaviors. The neuronal degeneration
caused by MSG in the brain’s hippocampal area might be
considered a reason why such behavioral effects happen.
Neurochemical parameters also support those findings
and results.
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